Signature Resources Capital Management, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1940917
NEWPORT BEACH, CA
Position in TMO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$33,591
-$1,799 QoQ
Shares Held
67
-6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,456
of 2,602 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Signature Resources Capital Management, LLC holds $177,455 across 7 Diagnostics & Research names. TMO ranks #2 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
|
2,034 | $119,456 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
67 | $33,591 | |
| 3 | A |
Agilent Technologies, Inc.
|
90 | $11,954 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
12 | $6,317 | |
| 5 | ILMN |
Illumina, Inc.
|
32 | $5,626 | |
| 6 | WAT |
Waters Corp /De/
|
1 | $375 | |
| 7 | GRAL |
GRAIL, Inc.
|
2 | $136 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,591 | 67 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $35,390 | 72 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $22,019 | 38 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $17,460 | 36 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $14,596 | 36 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $17,913 | 36 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $18,728 | 36 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $28,454 | 46 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $25,438 | 46 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $6,393 | 11 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $5,838 | 11 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||